Globus Medical, Inc. (GMED): Price and Financial Metrics


Globus Medical, Inc. (GMED): $75.18

1.14 (+1.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GMED POWR Grades

  • Growth is the dimension where GMED ranks best; there it ranks ahead of 95.31% of US stocks.
  • GMED's strongest trending metric is Stability; it's been moving up over the last 177 days.
  • GMED's current lowest rank is in the Sentiment metric (where it is better than 31.48% of US stocks).

GMED Stock Summary

  • Price to trailing twelve month operating cash flow for GMED is currently 39.35, higher than 87.58% of US stocks with positive operating cash flow.
  • The ratio of debt to operating expenses for GLOBUS MEDICAL INC is higher than it is for about only 0.48% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.12 for GLOBUS MEDICAL INC; that's greater than it is for merely 10.01% of US stocks.
  • If you're looking for stocks that are quantitatively similar to GLOBUS MEDICAL INC, a group of peers worth examining would be LMAT, NSSC, CTS, LOGI, and MASI.
  • Visit GMED's SEC page to see the company's official filings. To visit the company's web site, go to www.globusmedical.com.

GMED Valuation Summary

  • In comparison to the median Healthcare stock, GMED's price/sales ratio is 260.98% higher, now standing at 7.4.
  • Over the past 127 months, GMED's EV/EBIT ratio has gone up 28.4.

Below are key valuation metrics over time for GMED.

Stock Date P/S P/B P/E EV/EBIT
GMED 2023-01-20 7.4 4.2 47.6 38.2
GMED 2023-01-19 7.2 4.1 46.5 37.3
GMED 2023-01-18 7.2 4.1 46.3 37.2
GMED 2023-01-17 7.3 4.1 46.9 37.6
GMED 2023-01-13 7.4 4.2 47.9 38.4
GMED 2023-01-12 7.4 4.2 47.3 38.0

GMED Growth Metrics

    Its 2 year revenue growth rate is now at 21.22%.
  • Its 4 year net income to common stockholders growth rate is now at 40.84%.
  • Its 5 year cash and equivalents growth rate is now at -8.84%.
GMED's revenue has moved up $212,998,000 over the prior 33 months.

The table below shows GMED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 998.366 190.746 155.211
2022-06-30 973.939 235.088 154.991
2022-03-31 961.307 257.394 141.946
2021-12-31 958.102 276.274 149.191
2021-09-30 941.526 280.205 187.042
2021-06-30 927.903 256.191 184.047

GMED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • GMED has a Quality Grade of B, ranking ahead of 90.91% of graded US stocks.
  • GMED's asset turnover comes in at 0.547 -- ranking 84th of 186 Medical Equipment stocks.
  • OFIX, SRTS, and ESMC are the stocks whose asset turnover ratios are most correlated with GMED.

The table below shows GMED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.547 0.745 0.189
2021-03-31 0.514 0.729 0.131
2020-12-31 0.512 0.724 0.111
2020-09-30 0.510 0.732 0.103
2020-06-30 0.504 0.741 0.096
2020-03-31 0.542 0.764 0.165

GMED Stock Price Chart Interactive Chart >

Price chart for GMED

GMED Price/Volume Stats

Current price $75.18 52-week high $81.78
Prev. close $74.04 52-week low $52.60
Day low $74.04 Volume 287,500
Day high $75.26 Avg. volume 491,812
50-day MA $72.60 Dividend yield N/A
200-day MA $65.06 Market Cap 7.51B

Globus Medical, Inc. (GMED) Company Bio


Globus Medical focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company was founded in 2003 and is based in Audubon, Pennsylvania.


GMED Latest News Stream


Event/Time News Detail
Loading, please wait...

GMED Latest Social Stream


Loading social stream, please wait...

View Full GMED Social Stream

Latest GMED News From Around the Web

Below are the latest news stories about GLOBUS MEDICAL INC that investors may wish to consider to help them evaluate GMED as an investment opportunity.

Here's Why Investors Should Retain Globus Medical (GMED) Stock

Investors are optimistic about Globus Medical's (GMED) robust performance across several international markets.

Yahoo | January 16, 2023

15 Largest Orthopedic Companies in the World

In this article, we will take a look at the 15 largest orthopedic companies in the world. If you want to see more companies in this selection, go to the 5 Largest Orthopedic Companies in the World. The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to […]

Yahoo | January 14, 2023

Globus Medical, Inc. (NYSE:GMED) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Globus Medical (NYSE:GMED) has had a great run on the share market with its stock up by a significant 21% over the last...

Yahoo | January 11, 2023

Globus Medical Stock: A Long-Term Investment (NYSE:GMED)

Globus Medical develops compelling solutions for patients with musculoskeletal disorders. Read more to see GMED''s product pipeline and why it''s a long-term buy.

Seeking Alpha | January 8, 2023

Globus Medical (GMED) Global Growth Strong Despite Margin Woe

Despite continued margin declines in Japan, Globus Medical (GMED) remains positive on the progress and potential of its international business for long-term growth as it continues to reset the market in the country.

Yahoo | December 30, 2022

Read More 'GMED' Stories Here

GMED Price Returns

1-mo 3.30%
3-mo 11.86%
6-mo 28.10%
1-year 18.06%
3-year 40.47%
5-year 59.75%
YTD 1.23%
2022 2.87%
2021 10.70%
2020 10.77%
2019 36.04%
2018 5.30%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7159 seconds.